###begin article-title 0
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
PITX2 gain-of-function induced defects in mouse forelimb development
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 225 231 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx2 </italic>
Limb development and patterning originate from a complex interplay between the skeletal elements, tendons, and muscles of the limb. One of the genes involved in patterning of limb muscles is the homeobox transcription factor Pitx2 but its role in forelimb development is uncharacterized. Pitx2 is expressed in the majority of premature presumptive forelimb musculature at embryonic day 12.5 and then maintained throughout embryogenesis to adult skeletal muscle.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 77 92 <span type="species:ncbi:10090">transgenic mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
To further study the role of Pitx2 in forelimb development we have generated transgenic mice that exhibit a pulse of PITX2 over-expression at embryonic day 13.5 and 14.5 in the developing forelimb mesenchyme. These mice exhibit a distal misplacement of the biceps brachii insertion during embryogenesis, which twists the forelimb musculature resulting in severe skeletal malformations. The skeletal malformations have some similarities to the forearm deformities present in Leri-Weill dyschondrosteosis.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Taken together, the tendon, muscle, and bone anomalies further support a role of Pitx2 in forelimb development and may also shed light on the interaction between the skeletal elements and muscles of the limb during embryogenesis.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 949 955 949 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 </italic>
###xml 1095 1096 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1097 1098 1097 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1139 1141 1139 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1264 1265 1264 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1456 1457 1456 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1696 1697 1696 1697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1698 1699 1698 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1960 1964 1960 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eya1</italic>
###xml 1966 1970 1966 1970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eya2</italic>
###xml 1972 1976 1972 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six1</italic>
###xml 1982 1987 1982 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six2 </italic>
###xml 1996 2006 1996 2006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eya1, Eya2</italic>
###xml 2008 2013 2008 2013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six1 </italic>
###xml 2017 2022 2017 2022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six2 </italic>
###xml 2068 2069 2068 2069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 2070 2071 2070 2071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 2072 2074 2072 2074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 2264 2266 2264 2266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 2496 2500 2496 2500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera</italic>
###xml 2606 2608 2606 2608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 2863 2865 2863 2865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2866 2868 2866 2868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2875 2880 2875 2880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera </italic>
###xml 2944 2946 2944 2946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2947 2949 2947 2949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 3944 3946 3944 3946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 120 125 <span type="species:ncbi:10090">Mouse</span>
###xml 2346 2350 <span type="species:ncbi:10090">mice</span>
###xml 2479 2484 <span type="species:ncbi:10090">mouse</span>
###xml 2910 2915 <span type="species:ncbi:10090">mouse</span>
###xml 3034 3038 <span type="species:ncbi:10090">mice</span>
###xml 3373 3378 <span type="species:ncbi:10090">mouse</span>
Limb development and patterning originate from close interactions between tendon, cartilage and muscle precursor cells. Mouse forelimb development is first evident at about embryonic day (E) 9.5. Approximately 24 h later myogenic cells are identified at the base of the forelimb and at E11.5 the first hint of humerus is apparent [1]. At E14.5 a miniature model of the forelimb has been formed. Limb muscle precursors migrate from the lateral part of the somites into the limb bud where they undergo final differentiation. Among the transcription factors involved in early myogenesis are Pax3 and Lbx1 whose expression precedes the expression of myogenic regulatory factors (MRFs). MRFs belong to the MyoD family of basic helix-loop-helix factors. In mammals there are four such factors: Myf5, MyoD, myogenin, and MRF4 [2]. Little is known about the mechanisms whereby these genes regulate limb muscle development. The homeobox transcription factor PITX2 was originally identified as one of the genes responsible for Axenfeld-Rieger syndrome, mainly affecting eyes, teeth, and abdominal organs [3,4]. Pitx2 is expressed in a subset of Pax3+ limb muscle precursors already at E10.5. By E12.5 Pitx2 is expressed in all limb musculature and persists until adulthood [5]. Still, Pitx2 null mutants form nearly all muscle anlagen even though several of these muscle anlagen are distorted, coupled with malformation of the part of the body to which they attach [6]. Muscles attach to bone through tendons. Limb tendon cells originate from lateral plate mesoderm and tendon progenitor cells are regionalized in the dorsal and ventral areas of the limb where they are mixed with muscle progenitor cells [7,8]. Compared to other mesodermal tissues, such as blood vessels, cartilage, bone, and muscles, very little is known about the early formation and role of tendons during development. Among the transcription factors identified in developing tendons are scleraxis, Eya1, Eya2, Six1, and Six2 of which Eya1, Eya2, Six1 and Six2 are also expressed in limb muscle precursors [7,9-11]. This parallel expression in myoblast precursors of somite origin and in mesenchymal cells derived from the lateral plate may ensure correct and concerted migration of the two cell types [12]. To further study the role of Pitx2 in forelimb development we have generated mice that exhibit a brief pulse of PITX2 over-expression in the forelimb mesenchyme from E13.5 to E14.5. The expression is driven by mouse keratocan (Kera) 5'-flanking sequence, which has been used previously to achieve over-expression of PITX2 in the cornea [13]. The construct was termed Ktcn-PITX2. Keratocan is one of three major components of the extracellular keratan sulfate proteoglycans present mainly in vertebrate corneal stroma but also expressed in non-ocular tissues such as skeletal muscle and tendon [14,15]. The Kera gene is expressed in limbs of mouse embryos at E13.5 and E14.5 [16,17]. This is the first report of PITX2 over-expression in the forelimb. The Ktcn-PITX2 mice exhibit PITX2 over-expression in the anterior forelimb mesenchyme extending from the humerus to the radius. The cells over-expressing PITX2 are of non-myogenic origin and co-express Six2. As Six2 is involved in tendon development, we hypothesize that the observed expression disturbs correct muscle insertion, which in the Ktcn-PITX2 mouse leads to a random left-right distal misplacement of the biceps brachii insertion. This in turn results in a 180 degrees twist of the forelimb musculature. The muscle and tendon anomalies also lead to severe skeletal malformations consisting of a shortened, thickened and malformed humerus, a bowed ulna and a deformed radius. These skeletal malformations have some similarities to the pathogenesis of Leri-Weill dyschondrosteosis, which is characterized by disproportionate short stature and a characteristic curving of the radius, known as the Madelung deformity [18]. In conclusion, these findings may increase our understanding about the role of Pitx2 in limb development and on the interactions between muscle, tendon, and bone during development.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Ktcn-PITX2 mice have shortened, thickened and malformed humerus, deformed radius and bowed ulna
###end title 11
###begin p 12
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
The Ktcn-PITX2 forelimb phenotype occurs randomly on either left or right forelimb. Occasionally both forelimbs are affected (Table 1). The bone malformations consist of a shortened, thickened and malformed humerus and a diminished deltoid tuberosity. The humerus malformation is most prominent distally and partly distorts the olecranon fossa. The olecranon fossa is a dorsal depression that receives the olecranon (elbow) of the ulna when the forearm is extended. This leads to a slight dislocation of the proximal ulna. Radius is bent proximally and approaches the elbow joint from a straight angel (Figure 1A). This locks the elbow in a simultaneous pronation-extension and forces the ulna to bend upwards to reach the carpals. The limitations in elbow movement in combination with the 180 degrees twist of the paw makes the forelimb insufficient to support on (Figure 1B). Hindlimbs, in contrast, do not exhibit any phenotype. The Ktcn-PITX2 mice are fertile and have normal life span.
###end p 12
###begin p 13
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Forelimbs of Ktcn-PITX2 mice exhibit severe bone malformations</bold>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
Forelimbs of Ktcn-PITX2 mice exhibit severe bone malformations. (A) X-ray images and Alizarin Red staining of wild type (left panel) and Ktcn-PITX2 (right panel) adult forelimbs. Right panel: Alizarin Red staining of Ktcn-PITX2 forelimb (ventral view) shows a diminished and misplaced deltoid tuberosity. The humerus and radius are malformed. Note the proximal bend of the radius, which results in a posterior misplacement. (B) A Ktcn-PITX2 mouse displays the characteristic forelimb phenotype. Abbreviations: dt, deltoid tuberosity; h, humerus; r, radius; u, ulna.
###end p 13
###begin p 14
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Distribution of phenotypes in 1-month-old wild type and Ktcn-PITX2 mice.
###end p 14
###begin title 15
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Limb malformations are present in E18.5 and in newborn Ktcn-PITX2 mice
###end title 15
###begin p 16
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
To investigate potential embryonic bone and cartilage anomalies we stained forelimbs from E18.5 and newborn mice with Alcian Blue and Alizarin Red. At E18.5 Ktcn-PITX2 mice display a diminished deltoid tuberosity and newborn Ktcn-PITX2 mice also exhibit a distal thickening of the humerus. The thickening tends to partly dislocate the radius anteriorly and also slightly dislocate the proximal part of the ulna in a more lateral-dorsal position, which makes the ulna appear twisted (Figure 2). Bone and cartilage zones were carefully examined at high resolution but appeared normal in the Ktcn-PITX2 forelimbs of all ages (data not shown).
###end p 16
###begin p 17
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Skeletal malformations are present in E18.5 and in newborn Ktcn-PITX2 mice</bold>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
Skeletal malformations are present in E18.5 and in newborn Ktcn-PITX2 mice. Alizarin Red and Alcian Blue stainings of forelimbs from E18.5 (upper section) and newborn (lower section) mice. Forelimbs of E18.5 and newborn Ktcn-PITX2 mice display a diminished deltoid tuberosity (*). Newborn Ktcn-PITX2 mice also exhibit a thickening of the distal humerus, which tends to partly dislocate the radius anteriorly and also slightly dislocate the proximal part of the ulna in a more lateral-dorsal position, which makes the ulna appear twisted (arrows).
###end p 17
###begin title 18
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Ktcn-PITX2 mice over-express PITX2 in the forelimbs
###end title 18
###begin p 19
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2A </italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera </italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera </italic>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 456 462 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 </italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera </italic>
###xml 662 669 662 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2A </italic>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kera </italic>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1066 1072 1066 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C,E,G</xref>
###xml 1075 1076 1075 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1425 1431 1425 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D,F,H</xref>
###xml 1619 1628 1619 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 1745 1747 1745 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2021 2025 2021 2025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C,D</xref>
###xml 2146 2148 2146 2148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2282 2283 2282 2283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 226 231 <span type="species:ncbi:9606">human</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 656 661 <span type="species:ncbi:9606">Human</span>
###xml 1796 1800 <span type="species:ncbi:10090">mice</span>
###xml 1927 1931 <span type="species:ncbi:10090">mice</span>
The Ktcn-PITX2 mouse model was originally made to study the function of the homeobox gene PITX2A in eye development and its role in the pathology of Axenfeld-Rieger syndrome and glaucoma [13]. The Ktcn-PITX2 mice over-express human PITX2A in the cornea and iris under the Kera promoter and upstream regulatory elements, but Kera is also expressed throughout the limbs of embryos from E13.5 to E14.5 [17]. To study whether the Ktcn-PITX2 mice express human PITX2 mRNA in the forelimbs at the same embryonic stages as Kera is expressed we isolated forelimb RNA from Ktcn-PITX2 embryos (E12.5, E13.5, E14.5, and E15.5) and performed semi-quantitative RT-PCR. Human PITX2A mRNA expression level peaked at E13.5 and E14.5 and declined thereafter, consistent with the expression pattern of Kera (Figure 3). Further, we used immunohistochemistry to study the expression pattern of PITX2 protein in the forelimbs at E13.5. In wild type embryos Pitx2 expression is restricted to well defined anterior and posterior muscle groups consistent with previous observations (Figure 4C,E,G) [5]. In the Ktcn-PITX2 forelimbs we observed a proximal anterior over-expression of PITX2 in the mesenchyme close to the humerus but also an anterior over-expression in the mesenchyme expanding from the elbow joint to the distal part of radius. These areas did not stain for muscle specific antibodies against Pax3, MyoD1, myogenin, or myosin (Figure 4D,F,H and data not shown). This could either be due to that the cells over-expressing PITX2 are not of myogenic origin, or muscle markers are down regulated as a result of the over-expression. In vitro studies have shown that Pitx2C over-expression promotes cell proliferation and arrests differentiation in myoblasts [19]. However, in the forelimbs of adult Ktcn-PITX2 mice, all muscle groups are present, indicating that the cells over-expressing PITX2 are of non-myogenic origin. In the Ktcn-PITX2 mice, we consistently observed PITX2 over-expression in both right and left forelimbs (Figure 5C,D). It has been reported that Pitx2 regulates the expression of cyclin D2 (Ccnd2) after Wnt induction in C2C12 myoblasts [20]. We did not detect any increased expression of Ccnd2 in the cells over-expressing PITX2 or any increased apoptotic activity (Figure 6). Notably, the region of over-expression is situated close to where the first phenotypes later appear.
###end p 19
###begin p 20
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 </italic>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of human <italic>PITX2 </italic>mRNA in forelimbs of Ktcn-PITX2 mice</bold>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 </italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
Expression of human PITX2 mRNA in forelimbs of Ktcn-PITX2 mice. Semi-quantitative RT-PCR of E12.5, E13.5, E14.5, and E15.5 Ktcn-PITX2 mouse forelimbs shows a PITX2 expression peak at E13.5-14.5.
###end p 20
###begin p 21
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 is over-expressed in non-myogenic cells</bold>
PITX2 is over-expressed in non-myogenic cells. (A and B) H&E stained sagittal paraffin sections of E13.5 wild type and Ktcn-PITX2 forelimbs. (C, E, G) Pitx2 is expressed in the musculature of wild type forelimbs (arrowheads) as evident from its co-expression with myosin. (D, F, H) PITX2 is over-expressed in the anterior mesenchyme reaching from the humerus to the distal part of radius (arrows). Note that the cells over-expressing PITX2 do not stain for muscle specific antibodies. Scale bar: 1 mm.
###end p 21
###begin p 22
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PITX2 is over-expressed in both right and left forelimbs of the Ktcn-PITX2 mice</bold>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
PITX2 is over-expressed in both right and left forelimbs of the Ktcn-PITX2 mice. (A and B) H&E stained sagittal paraffin sections of left and right forelimb from one individual E14.5 mouse. The marked areas are magnified in C and D. (C and D) Immunohistochemistry reveals PITX2 over-expression in both right and left forelimb. Scale bar: 0.5 mm.
###end p 22
###begin p 23
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Unchanged expression of Ccnd2 and no differences in apoptotic activity in the Ktcn-PITX2 forelimbs</bold>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
Unchanged expression of Ccnd2 and no differences in apoptotic activity in the Ktcn-PITX2 forelimbs. (A and B) H&E stained sagittal paraffin sections of forelimbs from E14.5 mice. The marked areas in A and B are magnified in C-H. (C-F) Double labeling immunohistochemistry reveals that the cells over-expressing PITX2 (D) do not display an increased expression of Ccnd2 (F). (G and H) TUNEL staining of sections from wild type and Ktcn-PITX2 forelimbs does not show any difference in apoptotic activity in the cells over-expressing PITX2. Scale bar: 0.5 mm.
###end p 23
###begin title 24
###xml 33 37 <span type="species:ncbi:10090">mice</span>
The biceps brachii of Ktcn-PITX2 mice has a misplaced insertion
###end title 24
###begin p 25
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
To gain a deeper understanding of the forelimb phenotype we dissected forelimbs from adult Ktcn-PITX2 mice. Despite the obvious twist of the musculature, all muscle groups are present and originate and insert correctly except for biceps brachii. Biceps brachii is a flexor muscle whose function is to decrease the joint angle at the elbow but also to supinate (turn palm superiorly or anteriorly) the forearm at the radioulnar joints. It originates at two separate sites in the scapula and inserts at the proximal part of the radius. In the Ktcn-PITX2 mice biceps brachii insertion is altered as its distal tendon is curled around the radius and inserts dorsally at the very most distal part of the bone (Figure 7). This would explain the limited elbow motion but also the permanent pronation of the Ktcn-PITX2 forelimbs. Muscle groups work as antagonists. If the supination movement is impaired its antagonist, the pronator, will dominate, which may result in the pronation position.
###end p 25
###begin p 26
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Forelimbs of adult Ktcn-PITX2 mice display tendon anomalies</bold>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
Forelimbs of adult Ktcn-PITX2 mice display tendon anomalies. (A and B) The adult Ktcn-PITX2 limb musculature is twisted 180 degrees compared to wild type. Still, all muscle groups are present. (C) Normally, biceps brachii inserts at the proximal part of the radius (white arrow). (D) In the Ktcn-PITX2 mice biceps brachii insertion is altered (white arrow) as its distal end is curled around the radius (black arrow) and inserts dorsally at the very most distal part of the bone.
###end p 26
###begin title 27
PITX2 and Six2 are co-expressed in non-myogenic cells in the Ktcn-PITX2 forelimbs
###end title 27
###begin p 28
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C,E</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D,F</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C&#8211;F</xref>
###xml 807 817 807 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 874 879 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Six2 </italic>
To study the molecular mechanism behind the Ktcn-PITX2 forelimb tendon anomalies and to further characterize the identity of the cells over-expressing PITX2, we analyzed the expression of Six2 in wild type and Ktcn-PITX2 forelimbs. At E13.5 both Pitx2 and Six2 are expressed in the developing forelimb musculature (Figure 8C,E), but in the Ktcn-PITX2 embryos, Six2 is also expressed in a limited area within the non-myogenic cells over-expressing PITX2 (Figure 8D,F). This co-expression is more evident 24 h later. At E14.5 Six2 expression overlaps a substantial area of the cells over-expressing PITX2 (Figure 9C-F). This suggests a relationship between Pitx2 and Six2 and indicates that at least part of the cells over-expressing PITX2 are involved in tendinous patterning. In addition, studies performed in silico show several potential Bicoid/Pitx2 binding sites in the Six2 promoter (data not shown).
###end p 28
###begin p 29
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">At E13.5 PITX2 and Six2 are co-expressed in a limited numbers of non-myogenic cells</bold>
At E13.5 PITX2 and Six2 are co-expressed in a limited numbers of non-myogenic cells. (A and B) H&E stained sagittal sections of E13.5 wild type and Ktcn-PITX2 forelimbs. (C-H) At E13.5 both Pitx2 and Six2 are expressed in the developing forelimb musculature (*). (D, F) In the Ktcn-PITX2 forelimb, Six2 is also expressed in a limited numbers of the non-myogenic cells over-expressing PITX2 (arrow). Scale bar: 1 mm.
###end p 29
###begin p 30
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">At E14.5 PITX2 and Six2 are fully co-expressed in non-myogenic cells</bold>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(</bold>
At E14.5 PITX2 and Six2 are fully co-expressed in non-myogenic cells. (A) H&E stained sagittal section of E14.5 Ktcn-PITX2 forelimb. The marked area is magnified in B-D. (B-D) At E14.5 Six2 expression overlaps a substantial area of the non-myogenic cells over-expressing PITX2. The marked areas are further magnified in E-F and overlaid in F'. Scale bar: 0.5 mm.
###end p 30
###begin title 31
Discussion
###end title 31
###begin p 32
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1518 1520 1518 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1679 1684 1679 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pitx1</italic>
###xml 1684 1688 1684 1688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1805 1807 1805 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1917 1919 1917 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1920 1922 1920 1922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1923 1925 1923 1925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 2257 2258 2257 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 2960 2962 2960 2962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 3138 3140 3138 3140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 3592 3594 3592 3594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 3595 3597 3595 3597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 3798 3800 3798 3800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 4148 4150 4148 4150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 957 962 <span type="species:ncbi:10090">mouse</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 2029 2033 <span type="species:ncbi:10090">mice</span>
###xml 3358 3363 <span type="species:ncbi:10090">mouse</span>
###xml 4269 4274 <span type="species:ncbi:10090">mouse</span>
Pitx2 acts in hindlimb development together with Pitx1 where the former specifies laterality and the latter determines hindlimb identity [21]. During forelimb development Pitx2 is expressed in almost all muscle anlagen from embryogenesis until adulthood [4,5,22-24]. We show here for the first time that over-expression of PITX2 in non-myogenic cells of the developing forelimb results in a distal misplacement of the biceps brachii insertion, which gives rise to severe bone malformations, randomly affecting left or right forelimb. The bone anomalies include a diminished deltoid tuberosity, a shortened, thickened and malformed humerus. In addition, it causes the radius to approach the elbow via a perpendicular bend, which in turn limits the elbow movement, and forces a dorsally dislocated ulna to curve over radius to reach the carpals. The phenotype worsens two to three weeks after birth, possibly due to the increased load on the forelimbs as the mouse starts to walk. On the other hand we frequently detected mice with both forelimbs affected from early on. Also, mice with only one affected leg never developed any phenotype on the supporting leg. The skeletal malformations have some similarities to the pathogenesis of Leri-Weill dyschondrosteosis, characterized by disproportionate short stature, curving of the radius, and subluxation of the distal end of the ulna. Mutations in the SHOX gene have been shown to cause the disorder. However, for 27% of the cases, no causative gene has been identified [25]. Pitx2 is expressed in the left lateral plate mesoderm and acts as an effector for left-right asymmetry in mesoderm derived organs such as lungs [26]. Also, Pitx1-/- embryos show left-right asymmetry in the severity of a hindlimb phenotype due to redundancy between Pitx1 and Pitx2 [21]. Still, the limbs are symmetrical. It has previously been shown that function of Pitx2 is dosage-sensitive [13,27,28]. Hence, the more plausible explanation for the random left-right forelimb anomalies of the Ktcn-PITX2 mice could be minor differences in PITX2 expression levels between left and right. Pitx2 expression in limbs is restricted to muscle lineages and it has recently been shown that Pitx2 is one of the most complete muscle markers [5]. Immunohistochemistry on wild type forelimb sections demonstrate co-expression of Pitx2 and other muscle markers such as MyoD, myogenin, and myosin. In contrast, the cells over-expressing PITX2 in the Ktcn-PITX2 forelimbs do not express any of these muscle markers. Based on the observed tendon anomalies in the Ktcn-PITX2 forelimbs we stained for Six2, normally expressed in developing tendons. Co-expression of PITX2 and Six2 could indicate that the cells over-expressing PITX2 are involved in tendon development and positioning. The factors regulating correct attachments of tendons to bone and the time of commitment of tendon precursors to a tendon cell fate in vertebrates are largely unknown [29]. However, reports have shown that myotubes can induce tendon primordial into individual tendons and, moreover, if tendon precursors are removed, myotubes attach ectopically [30]. It is possible that the observed expression of Six2 in the cells over-expressing PITX2 interferes with the signals coordinating correct tendon insertion. Based on the observed co-expression of PITX2 and Six2 in our mouse model it is intriguing to note that both transcription factors are expressed during other developmental processes. Neural crest cells that migrate to the periocular mesenchyme during eye development express both Pitx2 and Six2 [31,32]. In addition, Eya1, another limb tendon marker, is expressed in developing anterior chamber structures of the eye including the iris, ciliary structures, and cornea, tissues that also express Pitx2 [12]. It would be interesting to further study a possible relation between Pitx2, Six2, and Eya1. Notably, Pitx1 is closely related to Pitx2 and normally involved in and restricted to hindlimb development. When ectopically expressed in the forelimbs it induces transformation and translocation of specific muscles, tendons, and bones of the forelimb [33]. Finally, the temporal overlap of muscle and tendon formation with the over-expression of PITX2 makes the Ktcn-PITX2 mouse an appropriate animal model to study the development of the musculoskeletal system.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Over-expression of PITX2 during mouse forelimb development results in severe tendon, muscle, and bone anomalies. These observations further support a role of Pitx2 in forelimb development. This animal model may also be valuable for future studies on the interaction between the skeletal elements and muscles of the limb during embryogenesis and it could provide information on new regulatory pathways involving PITX2.
###end p 34
###begin title 35
Methods
###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 36
###begin p 37
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Transgenic animals were previously described [13]. The local ethics committee for animal research has approved of our experiments (Lund district). The mice were housed and treated according to guidelines of national and local animal ethics guidelines at the BMC animal facilities at Lund University, Lund.
###end p 37
###begin title 38
RNA isolation and RT-PCR
###end title 38
###begin p 39
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">free </italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rps18</italic>
###xml 699 706 699 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PITX2A </italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rps18 </italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
We used Trizol (InVitrogen, Carlsbad, CA) and RNeasy MinElute Clean-up (Qiagen, Valencia, CA) kits to isolate total RNA from limbs. Tissues were whole forelimbs frozen in liquid nitrogen, grinded on dry ice, and further homogenized in Trizol with syringes. RNA was purified with phenol/chloroform, precipitated, and treated with DNA-free (Ambion, Austin, TX) to remove contaminating DNA. Reverse transcription was performed using SuperscriptII (Gibco/BRL/InVitrogen, Carlsbad, CA). We used a mixture of random hexamer and oligo-dT primers (Promega, Madison, WI) according to the recommendations of the manufacturer. We used an amplicon for ribosomal binding protein 18 (Rps18) as a loading control. PITX2A and Rps18 were amplified as described [13].
###end p 39
###begin title 40
Histological techniques
###end title 40
###begin p 41
###xml 351 353 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 566 570 <span type="species:ncbi:9925">goat</span>
###xml 576 582 <span type="species:ncbi:9986">rabbit</span>
###xml 599 603 <span type="species:ncbi:9925">goat</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
###xml 624 630 <span type="species:ncbi:9986">rabbit</span>
###xml 636 640 <span type="species:ncbi:9925">goat</span>
Limbs were fixed in 4% formaldehyde in PBS and then embedded in paraffin according to standard procedures. Sections of 5 mum were mounted on slides. Sections for immunohistochemistry were deparaffinized and boiled in 0.1 M sodium citrate and 0.05% Tween 20 for 15 minutes prior to over night primary antibody staining. Antibodies were against PITX2A [32], cyclin D2 (Abcam, Cambridge, UK), myosin (My32), MyoD1 (SIGMA, Saint Louis, MO), Pax3, myogenin (F5D) (Developmental Studies Hybridoma Bank, Iowa City, IA), and Six2 (Affinity Bioreagents, Golden, CO). We used goat anti-rabbit Alexafluor 546, goat anti-mouse 488, and rabbit-anti-goat Alexafluor 546 as secondary antibodies (Molecular Probes, Eugene, OR). Slides were mounted in Permafluor (Beckman-Coulter, Fullerton, CA).
###end p 41
###begin title 42
Terminal dUTP nick-end labeling (TUNEL) assay
###end title 42
###begin p 43
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
We used the In situ cell death detection kit fluorescein (Roche, Indianapolis, IN), to test apoptotic activity on 5 mum paraffin sections according to the recommendations of the manufacturer. Slides were mounted in Permafluor (Beckman-Coulter) and viewed in a fluorescence microscope.
###end p 43
###begin title 44
Bone and cartilage staining
###end title 44
###begin p 45
Embryos and newborn animals were skinned, eviscerated and fixed in 95% ethanol for one week. The specimens were then placed in acetone for one week, stained in 1 volume 0,1% filtered alizarin red S (SIGMA), 1 volume 0,3% filtered alcian blue 8GX (SIGMA), 1 volume 99.8% acetic acid, and 17 volumes 70% ethanol for one week, cleared in 1% KOH, destained in 20% glycerol + 1% KOH, and transferred through a graded glycerol series and stored in 100% glycerol.
###end p 45
###begin title 46
X-ray imaging
###end title 46
###begin p 47
###xml 4 8 <span type="species:ncbi:10090">mice</span>
The mice were sacrificed before X-ray exposure. A clinical Arco Ceil, Arcoma, Generator CPI Indico 100, and Canon CXDI-31 Portable DR System were used. Exposure settings were: 46 kV, 1.6 mAs.
###end p 47
###begin title 48
Authors' contributions
###end title 48
###begin p 49
JH helped with experimental design, performed the experiments, and drafted the manuscript. GI, CJ, and PL carried out the X-ray imaging and helped to draft the manuscript. TAH conceived and designed the experiments and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 49
###begin title 50
Acknowledgements
###end title 50
###begin p 51
We thank Dr. Lena Persson-Feld and staff at Lund University Animal Care facilities; Dr. Madeleine Durbeej-Hjalt and Mikael Akerlund for helpful discussions. Supported by the Swedish Research Council (to T.A.H) and Craafordska Stiftelsen (to T.A.H).
###end p 51
###begin article-title 52
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Tissue patterning in the developing mouse limb
###end article-title 52
###begin article-title 53
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse limb muscle is determined in the absence of the earliest myogenic factor myf-5
###end article-title 53
###begin article-title 54
Current molecular understanding of Axenfeld-Rieger syndrome
###end article-title 54
###begin article-title 55
Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome
###end article-title 55
###begin article-title 56
Expression pattern of the homeodomain transcription factor Pitx2 during muscle development
###end article-title 56
###begin article-title 57
Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch
###end article-title 57
###begin article-title 58
Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments
###end article-title 58
###begin article-title 59
Tendon and ligament: development, repair and disease
###end article-title 59
###begin article-title 60
Homeobox genes and connective tissue patterning
###end article-title 60
###begin article-title 61
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function
###end article-title 61
###begin article-title 62
Extraocular muscle is defined by a fundamentally distinct gene expression profile
###end article-title 62
###begin article-title 63
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 28 38 <span type="species:ncbi:7227">Drosophila</span>
Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode
###end article-title 63
###begin article-title 64
PITX2 gain-of-function in Rieger syndrome eye model
###end article-title 64
###begin article-title 65
###xml 56 62 <span type="species:ncbi:9913">Bovine</span>
Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A
###end article-title 65
###begin article-title 66
###xml 83 88 <span type="species:ncbi:9031">chick</span>
The keratocan gene is expressed in both ocular and non-ocular tissues during early chick development
###end article-title 66
###begin article-title 67
###xml 42 48 <span type="species:ncbi:9913">bovine</span>
###xml 123 129 <span type="species:ncbi:9913">bovine</span>
Sequence and structural implications of a bovine corneal keratan sulfate proteoglycan core protein. Protein 37B represents bovine lumican and proteins 37A and 25 are unique
###end article-title 67
###begin article-title 68
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 149 164 <span type="species:ncbi:10090">transgenic mice</span>
Identification of a 3.2 kb 5'-flanking region of the murine keratocan gene that directs beta-galactosidase expression in the adult corneal stroma of transgenic mice
###end article-title 68
###begin article-title 69
SHOX mutations in dyschondrosteosis (Leri-Weill syndrome)
###end article-title 69
###begin article-title 70
Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts
###end article-title 70
###begin article-title 71
Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development
###end article-title 71
###begin article-title 72
Pitx1 and Pitx2 are required for development of hindlimb buds
###end article-title 72
###begin article-title 73
###xml 71 76 <span type="species:ncbi:9606">human</span>
Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene
###end article-title 73
###begin article-title 74
Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain
###end article-title 74
###begin article-title 75
Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development
###end article-title 75
###begin article-title 76
SHOX point mutations and deletions in Leri-Weill dyschondrosteosis
###end article-title 76
###begin article-title 77
The transcription factor Pitx2 mediates situs-specific morphogenesis in response to left-right asymmetric signals
###end article-title 77
###begin article-title 78
Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose
###end article-title 78
###begin article-title 79
Dosage requirement of Pitx2 for development of multiple organs
###end article-title 79
###begin article-title 80
Muscle building; mechanisms of myotube guidance and attachment site selection
###end article-title 80
###begin article-title 81
Muscle and tendon morphogenesis in the avian hind limb
###end article-title 81
###begin article-title 82
PAX6 expression identifies progenitor cells for corneal keratocytes
###end article-title 82
###begin article-title 83
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
The Pitx2 protein in mouse development
###end article-title 83
###begin article-title 84
Pitx1 determines the morphology of muscle, tendon, and bones of the hindlimb
###end article-title 84

